These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions. Elens L; Langman LJ; Hesselink DA; Bergan S; Moes DJAR; Molinaro M; Venkataramanan R; Lemaitre F Ther Drug Monit; 2020 Jun; 42(3):360-368. PubMed ID: 32304488 [TBL] [Abstract][Full Text] [Related]
24. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City. Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850 [TBL] [Abstract][Full Text] [Related]
25. Slow Recovery from Critical Coronavirus Disease 2019 Pneumonia in an Immunosuppressed Renal Transplant Recipient with Early Acute Cardiorenal Syndrome. Zhu L; Shu H; Li H; Qiu T; Zhou J; Chen G Cardiorenal Med; 2020; 10(6):470-475. PubMed ID: 32987381 [TBL] [Abstract][Full Text] [Related]
26. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
27. Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient. Boix-Vilanova J; Gracia-Darder I; Saus C; Ramos D; Llull A; Santonja C; Del Pozo LJ; Martín-Santiago A Int J Dermatol; 2020 Oct; 59(10):1290-1292. PubMed ID: 32880914 [No Abstract] [Full Text] [Related]
28. COVID-19 in recent heart transplant recipients: Clinicopathologic features and early outcomes. Lima B; Gibson GT; Vullaganti S; Malhame K; Maybaum S; Hussain ST; Shah S; Majure DT; Wallach F; Jang K; Bijol V; Esposito MJ; Williamson AK; Thomas RM; Bhuiya TA; Fernandez HA; Stevens GR Transpl Infect Dis; 2020 Oct; 22(5):e13382. PubMed ID: 32583620 [TBL] [Abstract][Full Text] [Related]
29. Kidney Transplantation and COVID-19. Merhi B; Gohh R R I Med J (2013); 2020 Sep; 103(8):34-37. PubMed ID: 32900010 [No Abstract] [Full Text] [Related]
30. [Hematopoietic stem cell transplantation during the COVID-19 pandemic with reference to EBMT recommendation]. Atsuta Y; Doki N Rinsho Ketsueki; 2021; 62(2):106-114. PubMed ID: 33678769 [TBL] [Abstract][Full Text] [Related]
31. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients. Qin CX; Moore LW; Anjan S; Rahamimov R; Sifri CD; Ali NM; Morales MK; Tsapepas DS; Basic-Jukic N; Miller RA; van Duin D; Santella RN; Wadei HM; Shah PD; Gage N; Malinis M; Aslam S; Todesco E; Werbel WA; Avery RK; Segev DL Transplantation; 2021 Nov; 105(11):e265-e266. PubMed ID: 34310531 [No Abstract] [Full Text] [Related]
32. Clinical Effects of COVID-19 on Hematopoietic Stem Cell Transplant Outcomes in Pediatric Patients. Barhoom D; Mohseni R; Hamidieh AA; Mohammadpour M; Sharifzadeh M; Navaeian A; Taebi S; Behfar M Exp Clin Transplant; 2021 May; 19(5):501-507. PubMed ID: 34053422 [TBL] [Abstract][Full Text] [Related]
33. How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat? Dholaria B; Savani BN Br J Haematol; 2020 Apr; 189(2):239-240. PubMed ID: 32180224 [No Abstract] [Full Text] [Related]
34. A family cluster of diagnosed coronavirus disease 2019 (COVID-19) kidney transplant recipient in Thailand. Sakulkonkij P; Bruminhent J; Pankongngam C; Chalermphunchai N Immun Inflamm Dis; 2020 Dec; 8(4):534-543. PubMed ID: 32770646 [TBL] [Abstract][Full Text] [Related]
35. Hyponatremia: A possible immuno-neuroendocrine interface with COVID-19 in a kidney transplant recipient. Tantisattamo E; Reddy UG; Duong DK; Ferrey AJ; Ichii H; Dafoe DC; Kalantar-Zadeh K Transpl Infect Dis; 2020 Dec; 22(6):e13355. PubMed ID: 32510756 [TBL] [Abstract][Full Text] [Related]
36. Strengths and weakness of diagnostic tests of SARS CoV-2 infection. Hernández-Pérez JM; Martín-González E; Pino-Yanes M Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315 [No Abstract] [Full Text] [Related]
38. How kids' immune systems can evade COVID. Nogrady B Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982 [No Abstract] [Full Text] [Related]
39. Management of patients with Behçet's disease during the COVID-19 pandemic. Dursun R; Temiz SA; Özer İ; Daye M; Ataseven A Dermatol Ther; 2020 Nov; 33(6):e14063. PubMed ID: 32710599 [TBL] [Abstract][Full Text] [Related]